VIRAFERON 18 MUI/3ml injectible solution medication leaflet

L03AB05 interferon alfa 2B • Antineoplastic and immunomodulating agents | Immunostimulants | Interferons

Interferon alfa-2B is a medication used for the treatment of various types of cancer, such as malignant melanoma and leukemia, as well as viral infections like hepatitis B and C. It works by stimulating the immune system and inhibiting viral replication.

The medication is administered as a subcutaneous or intramuscular injection, as directed by a doctor, usually several times a week. It is important for patients to follow the treatment regimen and undergo regular check-ups.

Patients should be aware of potential side effects, such as flu-like symptoms, fatigue, or depression. It is important to inform the doctor of any unusual symptoms.

Common side effects include flu-like symptoms, fatigue, and depression. In rare cases, severe reactions such as liver impairment or hematologic disorders may occur. Patients should be informed of these risks before starting treatment.

General data about VIRAFERON 18 MUI/3ml

Substance: interferon alfa 2B

Date of last drug list: 01-07-2013

Commercial code: W51795003

Concentration: 18MUI / 3ml

Pharmaceutical form: injectible solution

Quantity: 12

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for interferon alfa 2B

10MUI/ml, 18MUI, 18MUI/0.3ml, 18MUI/3ml, 18MUI/ml, 1MUI/ml, 25MUI/2.5ml, 30MUI, 30MUI/ml, 3MUI/0.5ml, 3MUI/ml, 5MUI/0.5ml, 5MUI/ml, 60MUI

Combinations with other substances